Neoplasia/BPH

	Association Between Sociodemographic Marginalization and Combination Therapy for Metastatic Hormone-Sensitive Prostate Cancer: Population-Based Cohort Study in Ontario, Canada. JCO Oncol Pract Nguyen DD, Satkunasivam R, Aminoltejari K, Hird A, Roy S, Morgan SC, Shayegan B, Kulkarni GS, Trinh QD, Rosella LC, Breau RH, Lalani AA, Wallis CJD. PMID: 41529225 [PubMed - as supplied by publisher]
	TESTOSTERONE DOES NOT DRIVE PROSTATE CANCER: PRESENTING THE NEW FRAMEWORK OF ANDROGEN ADEQUACY VERSUS INADEQUACY. J Urol Morgentaler A, Traish AM. PMID: 41529181 [PubMed - as supplied by publisher]
	Comparison of Oncologic and Functional Outcomes of Orifice Resection via Monopolar and Bipolar System in Bladder Tumors with Orifice Involvement. Urol Int Topcu YK, Yarimoglu S, Sefik E, Celik S, Bolat D, Bozkurt IH, Gunlusoy B, Degirmenci T. PMID: 41528962 [PubMed - as supplied by publisher]
	Trends in hypofractionated radiotherapy use among patients with breast or prostate cancer: a multicenter study in Osaka, Japan. J Radiat Res Ikawa T, Morishima T, Nakata K, Kuwabara Y, Kishimoto K, Kanayama N, Morimoto M, Konishi K, Miyashiro I. PMID: 41528887 [PubMed - as supplied by publisher]
	MRI-guided neurovascular bundle avoidance in high dose rate prostate brachytherapy. Brachytherapy Gerber DG, Dresser S, Yang X, Qiu RLJ, Jiang X, Desai S, Harms J, Patel SA, Hershatter B, Sebastian N, Dhere V, Liu T, Jani AB, Patel PR. PMID: 41528861 [PubMed - indexed for MEDLINE]
	Air Pollution, Lifestyle, and Genetic Risk: A Multidimensional Study of PM(2.5) Constituents and Prostate Cancer. J Urol Zhang F, Zhou J, Yang C, Wei S, Ma J. PMID: 41528828 [PubMed - as supplied by publisher]
	Mendelian randomization analysis of PKD1 in endometrial cancer and comparative multi-cancer study with renal cell carcinoma. Discov Oncol Pang X, Wang Y, Zhang Q, Gu L. PMID: 41528614 [PubMed - as supplied by publisher]
	TMPRSS2 rs12329760 variant as a prognostic marker for prostate cancer progression. Mol Biol Rep Elghazali K, Najih M, Sakhi Z, Ennaji Y, Laaraqui A, Tagajdid R, Amine A, Ennaji MM. PMID: 41528570 [PubMed - indexed for MEDLINE]
	Surgical outcomes after neoadjuvant avelumab with or without chemotherapy for Muscle-Invasive bladder cancer: a Post-Hoc analysis of the aura trial (Oncodistinct-004). World J Urol Mjaess G, Quackels T, Fantoni JC, Tricard T, Marcq G, Blanc J, Barthelemy P, Carnot A, Sideris S, Awada A, Chanza NM, Peltier A, Albisinni S, Diamand R, Roumeguère T. PMID: 41528535 [PubMed - indexed for MEDLINE]
	Retroperitoneal lymph node dissection for growing teratoma syndrome in testicular cancer: a systematic review of surgical outcomes. World J Urol Costa Silva A, Morgado A, Alturas Silva J, Oliveira P, Clarke N, Almeida Pinto R, Gulamhusein A. PMID: 41528533 [PubMed - in process]
	Repeat transurethral resection and contemporary oncologic outcomes among patients with non-muscle invasive urothelial carcinoma of the bladder. World J Urol Perez-Londoño A, Kaul S, Fleishman A, Korets R, Rayala H, Chang P, Wagner AA, Bellmunt J, Olumi AF, Gershman B. PMID: 41528510 [PubMed - indexed for MEDLINE]
	A current profile of digital health literacy: patients undergoing holmium laser enucleation of the prostate (HoLEP). Different outcomes with population variation. A new prospective study. Aging Male Co, Mert MS, Akyol YK, Can U, Çanakçi C, Di. PMID: 41527383 [PubMed - indexed for MEDLINE]
	Composite Wilms Tumor and Renal Cell Carcinoma: A Comprehensive Clinicopathologic, Immunohistochemical, and Molecular Study of 18 Tumors Highlighting an Uncommon Pediatric Renal Entity. Am J Surg Pathol Vujani, Paulson VA, Galluzzo L, Collini P, Roibon NG, Spreafico F, Mitrofanova A, Pryce J, McDermott M, O'Sullivan M, Orhan D, Sebire N, Tretiakova M. PMID: 41527366 [PubMed - as supplied by publisher]
	Prostate cancer with incidental thoracic splenosis: a diagnostic challenge unveiled by 18Â F-PSMA PET/CT imaging. J Cardiothorac Surg Vlaes B, Smets D, Corveleyn H, De Pauw V. PMID: 41527001 [PubMed - as supplied by publisher]
	Comparative analysis of EAU, AUA, and NCCN guidelines for the management of non-muscle invasive bladder cancer. BMC Urol Ayd, Aykaç A, Kaya C, Sungur M. PMID: 41526868 [PubMed - as supplied by publisher]
	Adaptive ensemble learning for prostate cancer classification on multi-modal MRI: reducing unnecessary biopsies. BMC Med Imaging Aymaz S, O, Aymaz , Ayd, Okatan AE, Kad, Bulut E. PMID: 41526840 [PubMed - as supplied by publisher]
	Second-look transurethral resection in high-grade Ta non-muscle invasive bladder cancer. World J Urol Régnier S, Gabriel PE, Ouzaid I, Moschini M, Soria F, D'Andrea D, Shariat SF, Budowski A, Poyet C, Roumiguie M, Maestro MÁ, Briganti A, Krajewski W, Hendricksen K, Veerman H, Afferi L, Mattei A, Di Bona C, Zamboni S, Simeone C, Thenault R, Verhoest G, Gontero P, Xylinas E. PMID: 41526608 [PubMed - indexed for MEDLINE]
	Immune-modulating medications: the masquerading culprit of epididymo-orchitis. BMJ Case Rep Buchinsky DS, Polenakovik HM, Hakim JI. PMID: 41526075 [PubMed - indexed for MEDLINE]
	CBCT-based Online Adaptive Radiotherapy for Prostate Cancer: Dosimetrical Aspects and Comparison to Non-Adaptive Conventional IGRT. Technol Cancer Res Treat Scheele NC, Fischer J, Hampe L, Niemeier T, Moldauer J, Schmitt D, Guhlich M, Leu M, Dröge LH, Strauß A, Rieken S, Fischer LA, El Shafie RA. PMID: 41525208 [PubMed - indexed for MEDLINE]
	A REtrospective Study to Describe the Real-World Treatment Landscape in Patients with Metastatic Castration-Resistant PROstate Cancer: REMPRO. Adv Ther Manneh R, Hashem T, Young JJ, Joshi A, Bahadir S, Omar A, Eid S, Elsayes A, Gonzalez F, Elsayed M, Kantharaju P. PMID: 41525044 [PubMed - as supplied by publisher]

Articles 1 - 20 / 184634

Page 1 of 9232



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy